BCM
BlueCrest Capital Management’s Bristol-Myers Squibb BMY Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-6,364
| Closed | -$345K | – | 93 |
|
|
2024
Q1 | $345K | Sell |
6,364
-52,701
| -89% | -$2.86M | 0.02% | 72 |
|
|
2023
Q4 | $3.03M | Buy |
59,065
+40,501
| +218% | +$2.08M | 0.12% | 45 |
|
|
2023
Q3 | $1.08M | Buy |
+18,564
| New | +$1.08M | 0.05% | 82 |
|
|
2019
Q4 | – | Sell |
-5,766
| Closed | -$292K | – | 392 |
|
|
2019
Q3 | $292K | Buy |
+5,766
| New | +$292K | 0.02% | 358 |
|
|
2019
Q2 | – | Hold |
0
| – | – | – | 474 |
|
|
2019
Q1 | – | Sell |
-13,153
| Closed | -$684K | – | 1172 |
|
|
2018
Q4 | $684K | Sell |
13,153
-1,616
| -11% | -$84K | 0.04% | 274 |
|
|
2018
Q3 | $917K | Buy |
14,769
+1,285
| +10% | +$79.8K | 0.02% | 464 |
|
|
2018
Q2 | $746K | Buy |
+13,484
| New | +$746K | 0.02% | 612 |
|
|
2017
Q3 | – | Sell |
-10,931
| Closed | -$609K | – | 830 |
|
|
2017
Q2 | $609K | Buy |
+10,931
| New | +$609K | 0.02% | 532 |
|
|
2017
Q1 | – | Sell |
-28,500
| Closed | -$1.67M | – | 729 |
|
|
2016
Q4 | $1.67M | Buy |
+28,500
| New | +$1.67M | 0.09% | 261 |
|
|
2016
Q1 | – | Sell |
-4,613
| Closed | -$317K | – | 726 |
|
|
2015
Q4 | $317K | Buy |
+4,613
| New | +$317K | 0.01% | 692 |
|